Moody Aldrich Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-327
| Closed | -$207K | – | 197 |
|
|
2025
Q1 | $207K | Buy |
+327
| New | +$207K | 0.04% | 162 |
|
|
2024
Q4 | – | Sell |
-271
| Closed | -$285K | – | 217 |
|
|
2024
Q3 | $285K | Sell |
271
-46
| -15% | -$48.4K | 0.05% | 167 |
|
|
2024
Q2 | $333K | Sell |
317
-1,539
| -83% | -$1.62M | 0.06% | 154 |
|
|
2024
Q1 | $1.79M | Sell |
1,856
-137
| -7% | -$132K | 0.3% | 108 |
|
|
2023
Q4 | $1.75M | Sell |
1,993
-55
| -3% | -$48.3K | 0.31% | 101 |
|
|
2023
Q3 | $1.69M | Buy |
+2,048
| New | +$1.69M | 0.32% | 94 |
|